web statistics
KineMed  ► About > Press Room > KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

News & Press Room

Forthcoming Events

 

KineMed’s President & CSO, Marc Hellerstein M.D., Ph.D. will  present at the American Association for Cancer Research Annual Meeting in San Diego, CA. Dr. Hellerstein will be participating in the session titled “Approaches and Challenges in Studying Cancer Metabolism," which will take place Saturday, April 5th  from 3:15 PM to 5:15 PM. Dr. Hellerstein’s presentation “Quantifying in vivo metabolic pathway fluxes and network dynamics using heavy water and  mass spectrometry: a new class of disease biomarkers” will be given between 4:15 PM and 4:40 PM on April 5th.


Latest News

KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

Presentations & WebCasts



 

Press & Public Relations Contact

We are always pleased to assist the press with queries about KineMed. Please visit our press contact page for more information.

Please Contact Us ‣‣

Older Press Releases

May 15, 2012
May 14, 2012
Apr 10, 2012
Mar 9, 2012
Mar 5, 2012
Feb 2, 2012
Jan 30, 2012
Jan 17, 2012
Jan 3, 2012
Sept 16, 2011
Sept 8, 2011
May 19, 2011
 
April 19, 2011
 
March 25, 2011
March 9, 2011
 
January 20, 2011
 
January 6, 2011
 
November 30, 2010
 
November 2, 2010

FUNCTIONALLY INTERPRETABLE BIOMARKERS FOR THE NEXT GENERATION OF DISEASE MANAGEMENT

Mr David Fineman  |  President & CEO

Download


5980 Horton Street | Suite 470 | Emeryville, CA 94608 | Tel.: USA [1] 510.655.6525 | Fax: [1] 510.655.6506 | TOLL-FREE: 855.KINEMED | E-mail: info@kinemed.com

 Copyright © 2013 KineMed, Inc.  |  All Rights Reserved  |  Privacy  |  Terms & Conditions